Aziyo Biologics to Report Third Quarter 2020 Financial Results on Thursday, November 19, 2020

Rhea-AI Summary

Aziyo Biologics, a regenerative medicine company, plans to release its third quarter earnings results on November 19, 2020, after market close. A conference call will follow at 4:30 p.m. Eastern Time. Investors can access the call via phone or through a live webcast on the company's website. Aziyo focuses on developing differentiated medical products that improve surgical outcomes, particularly for patients with implantable devices. Since its inception in 2015, the company has built a portfolio for cardiovascular, orthopedic, and reconstructive applications.

SILVER SPRING, Md., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that it plans to release its third quarter earnings results after market close on Thursday, November 19, 2020. Management will host a conference call to review the company’s financial performance starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day. The conference call will be concurrently webcast.

The link to the webcast will be available on the Aziyo Biologics, Inc. website at www.aziyo.com under the investor relations section and will be archived for future reference. To listen to the conference call, please dial (833) 665-0667 (US/Canada) or (914) 987-7319 (International) and use the conference ID number 7952289 approximately ten minutes prior to the start time.

About Aziyo Biologics
Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties. For more information, visit www.Aziyo.com.

Media:
Courtney Guyer
Aziyo Biologics, Inc.
PR@aziyo.com

Investors:
Leigh Salvo or Caroline Paul
Gilmartin Group
investors@aziyo.com

FAQ

When will Aziyo Biologics release its Q3 earnings results?

Aziyo Biologics plans to release its third quarter earnings results on November 19, 2020, after market close.

What time is the conference call for Aziyo Biologics' earnings report?

The conference call for Aziyo Biologics' earnings report will take place at 4:30 p.m. Eastern Time on November 19, 2020.

How can I listen to the Aziyo Biologics conference call?

You can listen to the Aziyo Biologics conference call by dialing (833) 665-0667 for US/Canada or (914) 987-7319 for international calls, using conference ID 7952289, or by accessing the live webcast on their website.

What is the focus of Aziyo Biologics?

Aziyo Biologics focuses on creating differentiated regenerative medicine products aimed at improving surgical outcomes, particularly for patients with implantable medical devices.